- Open Access
Increases in norepinephrine release and ovarian cyst formation during ageing in the rat
© Acuña et al; licensee BioMed Central Ltd. 2009
Received: 05 March 2009
Accepted: 16 June 2009
Published: 16 June 2009
Depletion of ovarian follicles is associated with the end of reproductive function in ageing females. Recently, it has been described that this process parallels increases in the concentration of norepinephrine (NE) in the rat ovary. In sexually mature rats, experimentally-induced increases in the sympathetic tone of the ovary is causally related to ovarian cyst formation and deranged follicular development. Thus, there is a possibility that increased ovarian NE concentrations represent changes in the activity of sympathetic nerves, which consequently participate in the process of ovarian cyst formation observed during ageing in the human and experimental animal models.
Sprague-Dawley rats between 6 and 14 months old were used to analyse the capacity of the ovary to release 3H-NE recently incorporated under transmural depolarisation in relation to changes in the ovarian follicular population. Morphometric analysis of ovarian follicles and real time PCR for Bcl2 and Bax mRNA were used to assess follicular atresia.
From 8 months old, the induced release of recently incorporated 3H-norepinephrine (3H-NE) from the ovary and ovarian NE concentrations increased, reaching their peak values at 12 months old and remained elevated up to 14 months old. Increases in sympathetic nerve activity paralleled changes in the follicular population, as well as disappearance of the corpus luteum. In contrast, luteinised follicles, precystic follicles, and cystic follicles increased. During this period, the relationship between Bax and Bcl2 mRNAs (the proapoptotic/antiapoptotic signals) increased, suggesting atresia as the principal mechanism contributing to the decreased follicular population. When NE tone was increased, the mRNA ratio favoured Bcl2 to Bax and antiapoptotic signals dominated this period of development. Thus, these changing ratios could be responsible for the increase in luteinised follicles, as well as precystic and cystic follicles.
These data suggest that the ageing process in the ovary of the Sprague-Dawley rat is accompanied by an increased sympathetic tone of the ovary. Consequently, this sympathetic change could be related to a neuroendocrine-driven formation of a polycystic condition similar to that observed in the sympathetic-activated adult ovary.
Reproductive senescence in mammals is a poorly understood process. Moreover, understanding the mechanism underlying the loss of ovarian function is especially important because of an increasingly aged population and the fact that pregnancy has been postponed continuously during recent decades [1, 2]. Diverse hypotheses for age-related dysfunction have been postulated. The loss of reproductive function with ageing has been correlated with depletion of the oocyte pool (ovarian levels), dysfunction at the central level (hypothalamus), or a combination of both processes [3–6]. In mice, the simple depletion of the ovarian pool of oocytes does not seem to be the primary factor involved in reproductive failure associated with age, which is supported by reports of a substantial oocyte pool remaining upon cycle termination . Female rats have an expected life span of 2–3 years, but exhibit an increasing frequency of irregular reproductive cycles during middle age (8–12 months) and become acyclic when they are old (17–21 months) [8, 9]. It has recently been determined that ageing in rats is accompanied by increasing NE levels in the ovary . Thus, ovarian NE could be involved in the loss of reproductive performance found since middle age. It has been reported previously [11–14] that an experimentally-induced increase in ovarian sympathetic tone in the adult rat is causally involved in the transformation of preovulatory follicles (through a chain of neurotrophic-dependent mechanisms) to a polycystic ovary condition (PCO) with a simultaneous loss of estrual cycling.
There is little information regarding the role of sympathetic activation within the ovary of middle aged animals and the potential involvement in the loss of reproductive function. If the recently reported increase in NE concentration  is related to increased nerve activity and not to an accumulation of NE during ageing in the ovary, it is probably responsible for the changes in follicular development accompanying the age related decreases in ovarian function. Since some studies have found decreased and others increased levels of NE during ageing [10, 15], the present work sought to correlate changes in NE concentration and the release capacity of the nerves with the dynamic changes in the ovary follicles and reproductive performance. This study could be especially important considering that once a PCO is established in humans, the condition does not disappear until senescence and it can even continue after menopause .
Changes in pregnancy rate during ageing
Number of pups born live
8.3 ± 0.6
10.7 ± 0.42
9.7 ± 0.43
6.8 ± 0.53
4.9 ± 0.87
2.6 ± 0.63
0.5 ± 1.89
All animal procedures were performed following protocols previously approved by the Institutional Ethic Committee of the Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, and experiments were conducted in accordance with the International Guiding Principles for Biomedical Research Involving Animals as promulgated by the Society for the Study of Reproduction. The animals were sacrificed by decapitation, trunk blood was collected, and serum was stored at 4°C in order to determinate progesterone, androstenedione, and estradiol levels. The ovaries were collected and immediately frozen at -80°C, with the exception of the four left-sided ovaries in each group that were fixed for morphological studies. In each rat, the stage of the estrual cycle was determined by microscopic analysis of the predominant cell type obtained from daily (Monday through Friday) vaginal smears. All rats were sacrificed during diestrus.
Fresh ovaries were immersed in Zamboni fixative, embedded in paraffin, cut into 6 um sections, and stained with hematoxylin and eosin. The presence of preantral, antral, atretic, precystic (type 3), and cystic follicles was analysed according to Lara et al. . All slices were analysed and preantral follicles corresponded to those with no antral cavity, i.e. primordial, primary and secondary follicles. Antral follicles presented with an antral cavity (antrum), i.e. tertiary and preovulatory follicles. Total preantral follicles corresponded to healthy and atretic follicles. The same procedure was followed to measure antral follicles. With the exception of primordial follicles (presenting flat cells around), preantral follicles were defined as follicles without any antral cavity and with one or more layers of granulosa cells. Atretic follicles were defined as those follicles with more than 5% of cells that had pyknotic nuclei in the largest cross-section and showed shrinkage and an occasional breakdown of the germinal vesicle. Antral follicles were counted when the nucleus of the oocyte was visualised. Cystic follicles were defined as those follicles devoid of oocytes and displaying a large antral cavity, an enlarged thecal cell layer, and a thin (mostly monolayer) granulosa-cell compartment that contained apparently healthy cells. Type 3 follicles were defined according to the criteria proposed by Brawer and colleagues [17, 18]. These follicles were large, devoid of oocytes, and contained four or five plicated layers of small, densely packed granulosa cells surrounding a very large antrum with a seemingly normal thecal compartment. Type 3 follicles may represent precystic follicular structures [17, 18]. Our previous observations suggested the existence of a transitional stage between healthy preovulatory follicles and the type 3 follicles previously described . Luteinised follicles are characterised by the presence of luteinised granulosa cells (a big cytoplasm similar to luteal cells), and have an antral cavity (although there is not an oocyte) .
Estradiol, androstenedione and progesterone assays
Serum estradiol, androstenedione, and progesterone levels were measured by an enzyme immunoassay (EIA) following the manufacturer's instructions (Alpco Diagnostics, Windham, New Hampshire, USA). Estradiol sensitivity was 10 ng/ml, and the intra- and inter-assay variations were less than 9.3% and 9.9%, respectively. Progesterone sensitivity was 0.1 ng/ml, and intra- and inter-assay variations were less than 10.6% and 12.6%, respectively. Androstenedone sensitivity was 0.05 ng/ml, and the intra- and inter-assay variations were less than 6.7% and 14.6%, respectively.
Determination of total adrenal catecholamines
The adrenal glands were weighed and homogenised in 500 μL of ice cold 0.2 N PCA. The homogenate was centrifuged at 12,000 g for 10 min at 4°C. The supernatants were used for colourimetric determination of total catecholamines. As previously reported , this method measures NE and epinephrine as a whole by the formation of noradrenochrome and adrenochrome (excitation wavelength of 540 nm) when the sample is oxidised with iodine at a pH higher than 6.0
Measurement of endogenous tissue NE content
One frozen ovary from each rat was homogenised in 200 μl 0.1 M acetic acid. Subsequently, 50 μl of the homogenate was precipitated with 180 μl 0.2 M HClO4 and centrifuged (15,000 g for 15 min). NE was measured in the supernatant by HPLC coupled with electrochemical detection . A 150 μl sample was mixed with 50 mg activated alumina in 1 ml TrisCl 1.5 M, pH 8.3–8.5, containing 2% EDTA. Dihydroxybenzyl amine (DHBA, 2000 pg in 20 μl; Sigma, St. Louis, Missouri, USA) was added as an internal standard. The alumina was rinsed thoroughly with nanopure water and NE was eluted with 100 μl of 0.2 N perchloric acid and centrifuged. Afterwards, 20 μl of the resulting 8 supernatants were injected into a Waters HPLC system equipped with a C18 reverse phase column (Lichrosphere, 60 RP-Select B, Merck, Darmstadt, FR Germany) and an electrochemical detector (Waters 464). The mobile phase contained 0.1 M NaH2PO4, 0.42 mM octyl-sulphate, 0.02% EDTA and 1.5% acetonitrile (pH 2.5) with a 0.9 ml/min flow rate. The potential of the amperometric detector was set to 0.7 V. Under these experimental conditions, the retention time was 4 min for NE and 10 min for DHBA.
Uptake and release of NE
The procedure was performed as previously described [22, 23], with some modifications. Rats were sacrificed at 6, 8, 12 and 14 months old. The ovaries were rapidly removed through an abdominal mid-line incision. One ovary was frozen at -80°C to isolate total RNA and the other was preincubated for 20 min in Krebs Ringer buffer (KRB) (pH 7.4), gassed with 95%O2-5%CO2, and then incubated for 30 min at 37°C with 2 μCi 3H-NE (New England Nuclear Life Science Products, Boston, Massachuesetts, USA). After washing the tissue in KRB (6 washes of 10 min each) to remove non-incorporated radioactivity, the ovaries were transferred to a thermoregulated superfusion chamber and perifused at a 1.5 ml/min flow rate for 10 min with KRB plus 10 mM tetraethylammonium, a potassium channel blocker which enhances the release of NE from nerve terminals in response to electrical stimulation [24, 25]. One-minute fractions were collected. After 3 min, the ovary was subjected to a train of monophasic electrical pulses (80 V, 10 Hz, 10 msec/pulse for 1 min), delivered through a parallel set of platinum electrodes that was generated by a Grass S-4 stimulator (Grass Instruments, Quincy, Massachuesetts, USA). One-minute fractions were collected for an additional 5 min. In each experiment, ovaries from the different age groups were simultaneously stimulated in parallel superfusion chambers. At the end of the experiment, the ovaries were homogenised in 0.4 M perchloric acid, and 3H-catecholamine remaining in the tissue was determined by scintillation counting in a Tri-Carb Liquid Scintillation Analyzer 1600TR (Packard Instruments, Meriden, Connecticut, USA), with 72.5% efficiency for 3H. These values were used to calculate the radioactivity remaining in the tissue after the experiment. In order to calculate the amount of NE released, the radioactivity present in each of the one-minute samples was determined in the same way. The release, which represented 3H-NE overflow from the ovaries, was then expressed as fractional release, i.e. as a percentage of the total radioactivity present in the tissue. The total amount of neurotransmitter released was calculated as the area under the curve after stimulation minus that for basal efflux [22, 24].
Reverse transcriptase reaction
Total RNA was extracted as described by Chomczynski and Sacchi  from whole ovaries. Total RNA (5 μg) was subjected to reverse transcription at 42°C for 50 min, using 1.6 mM dNTPs, 10 mM DTT, 176 nM random hexamers (Invitrogen, Carlsbad, California, USA), 25 U RNaseOUT (Invitrogen, Carlsbad, California, USA), 125 U reverse transcriptase SuperScript II (Invitrogen, Carlsbad, California, USA), and first strand buffer in a final volume of 30 μl. The reaction was terminated by heating the samples at 75°C for 10 min.
Real time PCR
For specific gene amplification, a standard protocol of 40 cycles was used in a MJ Research PT-200 (MJ Research Inc., Watertown, Massachusetts, USA.). A standard real-time PCR reaction mix was prepared containing the following components: 15 μl of Platinum SYBR Green PCR Super MIX UDG (Invitrogen, Carlsbad, CA), 2.4 mM MgCl2, 0.16 μM each primer and 2 μl cDNA. After initial polymerase activation at 95°C for 10 min, primer-specific amplification and quantification cycles were run at 60°C for 15 s and 72°C for 20 s. The fluorescence intensity of the double-strand specific SYBR-Green I, reflecting the amount of PCR-product actually formed was read at the end of each elongation step, after previous melting curve analyses to determine the melting points of the PCR products. Then, the amounts of specific initial template mRNA were calculated by determining the time point at which the linear increase of sample PCR product started relative to the corresponding points of a standard curve, which was obtained by serial dilutions of known copy numbers of the corresponding control tissue. To evaluate specific amplification, a final melting curve was created (72–95°C) under continuous fluorescent measurement.
The primers used for amplification were a forward primer (5-CAC-CCT-GGC-ATC-TTC-TCC-TT-3) and reverse primer (5-ACA-CAT-GAC-CCC-ACC-GAA-CTC-3) corresponding to Bcl2 mRNA (Genebank access NM_016993). The Bax primers were composed of a forward primer (5-AGG-CGA-ATT-GGC-GAT-GAA-CTG-3) and reverse primer (5-TTC-TGA-TCA-GCT-CGG-GCA-CTT-TAG-3) (Genebank access U49729). These primers were from Invitrogen/Life Technologies, Inc. To normalise the quantification of Bcl2 and Bax mRNAs, ribosomal 18s mRNA was measured in each protocol. Amounts of 18s mRNA were determined using a commercially available RT primer pair (Ambion, Austin, Texas, USA). Amplification of 18s mRNA was performed in a different tube to avoid interference with the amplification of the mRNAs. Reaction tubes lacking RT were used as PCR controls. The RT-PCR products were separated on 2.0% agarose gels, stained with ethidium bromide, and photographed digitally.
Differences between the different ages groups were analysed by one-way ANOVA, followed by the Student-Newman-Keuls multiple comparison test for unequal replication. The level of significance was set to P < 0.05.
Changes in the estrual cycling activity and reproductive performance during ageing in rat
Changes in follicular dynamics during ageing in the rat
Changes in hormone plasma levels in relation to follicular structures in the ovary
Changes in plasma norepinephrine and in the concentration of catecholamines in the adrenal gland, celiac ganglia, and ovary during ageing
Changes in NE concentrations during rats' ageing
Ovary weight (mg tissue/pair ovaries)
24.13 ± 3.0
23.11 ± 1.6
28.25 ± 3.7
27.57 ± 3.2
25.78 ± 2.6
Ovary (pg NE/mg)
157 ± 48
215 ± 27,5
231 ± 35a
375 ± 65.9b
216 ± 20.2
Plasma (pg NE/ml)
52.65 ± 9
48.9 ± 9
40.78 ± 9
35.95 ± 10
47.1 ± 11
Celiac Ganglion (ng NE/ganglia)
69.79 ± 8
55.5 ± 10.1
60 ± 14
22.8 ± 8.9c
30.2 ± 10c
Adrenal (μg catecholamines/mg)
2.14 ± 0.25
2.80 ± 0.6
3.82 ± 0.32
2.98 ± 0.21
3.7 ± 0.33
Changes in the release of recently incorporated norepinephrine from the ageing ovary
Changes in pro and antiapoptotic signalling in the ageing ovary
In the present paper, it was found that the ageing of ovarian function in Sprague-Dawley rats is accompanied by a spontaneous increase in the capacity of the sympathetic nerves of the ovary to release NE and to develop a polycystic condition. We used Sprague-Dawley rats because female rats have an expected life span of 2–3 years, thereby allowing an easier assessment of reproductive function in a relatively short period of time. In addition, almost all of the central and peripheral mechanisms involved in reproductive function either in males or females  have been initially described in rats and have been confirmed to occur in humans, thereby justifying its use as a model to understand reproductive function.
Changes in follicular dynamics with ageing in the Sprague-Dawley rat
Consistent with what has been observed in the reproductive cycles of perimenopausal women [28, 29], it was found that reproductive ageing in the Sprague-Dawley rat was characterised by a gradual shift from the normal 4–5 day estrous cycle to cycles of variable length. This result has been previously found by others [30, 31], and is characterised by an increasing proportion of nonovulatory cycles, and reduced numbers of developing ovarian follicles, which compromise fertility [32–34]. The age-related change in rodent estrous cyclicity seems to be attributed to the failure to continue producing progesterone in a cyclic fashion and, as it was found in the present study, a constant decrease in plasma progesterone up to 10 months old and older. Cessation of estrual cycling activity was correlated with an important decrease in the number of antral preovulatory follicles, suggesting that the ageing process is a consequence of the disappearance of the preovulatory follicle pool in the ovary. The constant decrease in the total follicular pool of the ovary was probably due to several reasons. First, a sharp decrease was found in the preantral follicle population during the 6 to 8 months old transition period. Second, the increased atresia of antral follicles reached their highest levels when rats were 10 months old. The correlation found between the morphological evidence of atresia, the increased ratio between atretic and healthy antral follicles, and the biochemical marker Bax, which was high compared to the mRNA for the antiapoptotic protein BCL2 until 10 months old, indicated that apoptosis predominates in ovarian follicles during the subfertile period . Interestingly, when the cessation of the fertility process started the relationship between the antiapoptotic and apoptotic proteins was reversed. This indicates that when the fertile period ceased (indicated by no estrous cycling activity, no ovulation, and disappearance of CL), the ovary developed mechanisms to increase survival of the remaining follicles. As a result, it presumably developed the new population of luteinised follicles. These luteinised follicles were derived from preovulatory follicles that were ordinarily not going to undergo ovulation. This finding suggested that even though ovulatory cycles had ended, the remaining preovulatory follicles did not go to atresia and they were induced to luteinisation or to become other non-atretic structures in the ovary such as type-3 and cystic follicles. Because of animal age and due to the loss of the capacity to maintain the estrous cycling activity, there is probably no LH preovulatory surge. Consequently, there are constant levels of LH and loss of the pulsatile secretory activity from the hypothalamus . Chavez-Genaro et al  recently described that when old rats (in the subfertile age period) are treated with gonadotropin, they are able to ovulate, suggesting a decrease in hypothalamic GnRH control to the hypophysis . Supporting a loss of pulsatile release of gonadotropin as a key factor in developing the morphological changes in the ovary, Risma et al  found that the ovaries of mice over-expressing LH were influenced by the constantly high LH levels that provoked strong changes in follicular development, stimulated the formation of luteinised follicles, and induced the appearance of type 3 and cystic follicles. If this were the case for the ageing ovary of the Sprague-Dawley rat, it could be the reason why there were a high number of precystic type-3 follicles and cystic follicles. Almost identical morphological changes in the ovary were described previously by Brawer et al  and were repeated in this research  by administrating estradiol valerate to sexually mature adult rats. Interestingly, this treatment demonstrated that there was a decrease (and not an increase as in LH-overexpressing mice) in LH levels, and most importantly; there was a loss of pulsatile activity. Thus, the changes in follicular dynamics could be independent of central mechanisms involving local regulators (probably intraovarian), which can then be stimulated by gonadotropins to provoke the loss of the preovulatory follicular pool. Sympathetic nerves are the target tissues for gonadotropins  and can be locally stimulated to increase their activity and modify follicular development.
Sympathetic nerve activity and development of a polycystic condition
It was previously described that a sexually mature adult rat treated with estradiol valerate (EV) developed a similar morphological change in the ovary similar to what we have described in the ovaries of ageing rats. These morphological changes were chronologically related with a previous increase in nerve activity (as measured by NE concentration), and with the capacity of the ovary to release recently incorporated 3H-NE after a depolarising stimulus [12, 13]. All of these changes were experimentally demonstrated to occur in the ageing rats. The fact that NE release capacity increased during ageing suggests a direct relationship between nerve activity and precystic and cystic structures in the ovary. According to the recent study of Chavez-Genaro , peripheral sympathetic denervation by treatment with guanethidine to decrease the NE in the ovary during the subfertile period did not provoke an increase in the number of ova shed in 12 month old denervated rats after gonadotropin stimulation. This finding suggests that if sympathetic nerves participate in the control of ovulatory function at the stage of preovulatory rupture of the follicle or in the recruitment of the follicular population, sympathetic tone may also participate in other steps of follicular development such as when the ageing ovary is marked by decreases in primordial, secondary, and preovulatory follicles. In this regard, sympathetic nerve activity has causally been related to a neurotrophin-induced increase in the activity of ovarian nerves [11, 13, 40], which stimulate the transition between preovulatory to cystic follicles. Thus, the lack of NE (denervation) probably decreased the number of preovulatory follicles going to type 3 and follicular cysts, and rescued them towards ovulation. Convery et al  demonstrated that hemiovarectomy of EV-induced polycystic ovary in rats, leads to ovulation of unhealthy (probably type-3) follicles. If this were the case for the ageing ovary, it could suggest that the increased sympathetic activity found in the ovary induced type 3 and cyst formation because atresia (as assessed by morphological and molecular approaches) decreased at this age. Considering that NE concentrations in the ovary of the rats used in this study increased until 12 months old and were maintained at this elevated level, the increase in antiapoptotic signal and NE activity could be parallel events. Currently, experiments are in progress to test for a causal relationship between increased NE activity and atresia. The fact that the concentration of NE in the celiac ganglia (where sympathetic neurons innervating the endocrine compartment of the ovary originate) decreased at an early age (similar to the plasma levels), strongly suggests that the decrease in the sympathetic nerve supply to the ovary with ageing is a consequence of a more generalised ageing process. It also suggests that the increased activity of the intraovarian compartment of the ovary could be attributed to the increase in local intraovarian signals in which nerve growth factor and its receptors could participate. This phenomena was previously demonstrated for cyst formation in sexually mature rats stimulated with EV [13, 40], despite the lack of change found in other tissues innervated by the celiac ganglia such as the adrenal gland.
Supporting this assertion, it has been demonstrated  that ovaries from postmenopausal women possess a higher density of sympathetic nerves and ovarian cystic conditions remain in women after menopause . Currently, it is difficult to support a direct relationship between sympathetic tone and ageing ovary function. Nevertheless, this is an important relationship; especially now that people are exposed to environmental factors which may modify their progression towards the end of the reproductive period, as we have demonstrated to occur in rats during early exposure to estradiol . In addition, this is important because women have postponed pregnancies to later in their fertile period due increasing social and/or economic demands. More studies in animal models will provide addition support clarifying the role of sympathetic nerve participation in ovary function during ageing.
Altogether, these data suggest that an increased intraovarian sympathetic tone participates in the processes that induce the polycystic condition associated with ageing in the Sprague-Dawley rat, and it has opened a new mechanism to control follicular development during natural ageing. The use of rats as a model to investigate the natural ageing of ovary function appears to be a useful model for studying the processes and mechanisms which control follicular development.
The current research was supported by Fondo Nacional de Ciencias, Proyecto 1061143 and 1090159 (to AHP). The authors thank N. Singer for helping with the final text and Francisco Cortés for helping with processing ovary sections.
- Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF: Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992, 7 (10): 1342-1346.PubMedGoogle Scholar
- te Velde ER, Dorland M, Broekmans FJ: Age at menopause as a marker of reproductive ageing. Maturitas. 1998, 30 (2): 119-125. 10.1016/S0378-5122(98)00067-X.View ArticlePubMedGoogle Scholar
- Labhsetwar AP: Age-dependent changes in the pituitary-gonadal relationship: a study of ovarian compensatory hypertrophy. J Endocrinol. 1967, 39 (3): 387-393. 10.1677/joe.0.0390387.View ArticlePubMedGoogle Scholar
- Butcher RL, Page RD: Introductory remarks: environmental and endogenous hazards to the female reproductive system. Environ Health Perspect. 1981, 38: 35-37. 10.2307/3429357.PubMed CentralView ArticlePubMedGoogle Scholar
- Nozaki M, Mitsunaga F, Shimizu K: Reproductive senescence in female Japanese monkeys (Macaca fuscata): age- and season-related changes in hypothalamic-pituitary-ovarian functions and fecundity rates. Biol Reprod. 1995, 52: 1250-1257. 10.1095/biolreprod52.6.1250.View ArticlePubMedGoogle Scholar
- Brann DW, Mahesh VB: The aging reproductive neuroendocrine axis. Steroids. 2005, 70: 273-283. 10.1016/j.steroids.2004.12.008.View ArticlePubMedGoogle Scholar
- Nelson JF, Gosden RG, Felicio LS: Effect of dietary restriction on estrous cyclicity and follicular reserves in aging C57BL/6J mice. Biol Reprod. 1985, 32: 515-522. 10.1095/biolreprod32.3.515.View ArticlePubMedGoogle Scholar
- Huang HH, Meites J: Reproductive capacity of aging female rats. Neuroendocrinology. 1975, 17: 289-295. 10.1159/000122367.View ArticlePubMedGoogle Scholar
- Wise PM: Neuroendocrine ageing: its impact on the reproductive system of the female rat. J Reprod Fertil Suppl. 1993, 46: 35-46.PubMedGoogle Scholar
- Chavez-Genaro R, Lombide P, Dominguez R, Rosas P, Vazquez-Cuevas F: Sympathetic pharmacological denervation in ageing rats: effects on ovulatory response and follicular population. Reprod Fertil Dev. 2007, 19 (8): 954-960. 10.1071/RD07075.View ArticlePubMedGoogle Scholar
- Barria A, Leyton V, Ojeda SR, Lara HE: Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology. 1993, 133: 2696-2703. 10.1210/en.133.6.2696.PubMedGoogle Scholar
- Lara HE, Ferruz JL, Luza S, Bustamante DA, Borges Y, Ojeda SR: Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology. 1993, 133: 2690-2695. 10.1210/en.133.6.2690.PubMedGoogle Scholar
- Lara HE, Dissen GA, Leyton V, Paredes A, Fuenzalida H, Fiedler JL, Ojeda SR: An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology. 2000, 141: 1059-1072. 10.1210/en.141.3.1059.PubMedGoogle Scholar
- Lara HE, Dorfman M, Venegas M, Luza SM, Luna SL, Mayerhofer A, Guimaraes MA, Rosa ESAA, Ramirez VD: Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release. Microsc Res Tech. 2002, 59: 495-502. 10.1002/jemt.10229.View ArticlePubMedGoogle Scholar
- Ferrante F, Bronzetti E, Cavallotti C, Ricci A, Amenta F: The noradrenergic innervation of the ovary in old rats. Mech Ageing Dev. 1990, 54: 55-61. 10.1016/0047-6374(90)90015-8.View ArticlePubMedGoogle Scholar
- Birdsall MA, Farquhar CM: Polycystic ovaries in pre and post-menopausal women. Clin Endocrinol (Oxf). 1996, 44: 269-276. 10.1046/j.1365-2265.1996.676498.x.View ArticleGoogle Scholar
- Brawer J, Richard M, Farookhi R: Pattern of human chorionic gonadotropin binding in the polycystic ovary. Am J Obstet Gynecol. 1989, 161 (2): 474-480.View ArticlePubMedGoogle Scholar
- Convery M, McCarthy GF, Brawer JR: Remission of the polycystic ovarian condition (PCO) in the rat following hemiovariectomy. Anat Rec. 1990, 226: 328-336. 10.1002/ar.1092260309.View ArticlePubMedGoogle Scholar
- Smith MF, McIntush EW, Smith GW: Mechanisms associated with corpus luteum development. J Anim Sci. 1994, 72 (7): 1857-1872.PubMedGoogle Scholar
- Lara HE, McDonald JK, Ahmed CE, Ojeda SR: Guanethidine-mediated destruction of ovarian sympathetic nerves disrupts ovarian development and function in rats. Endocrinology. 1990, 127 (5): 2199-2209.View ArticlePubMedGoogle Scholar
- Sotomayor-Zarate R, Dorfman M, Paredes A, Lara HE: Neonatal exposure to estradiol valerate programs ovarian sympathetic innervation and follicular development in the adult rat. Biol Reprod. 2008, 78: 673-680. 10.1095/biolreprod.107.063974.View ArticlePubMedGoogle Scholar
- Ricu M, Paredes A, Greiner M, Ojeda SR, Lara HE: Functional development of the ovarian noradrenergic innervation. Endocrinology. 2008, 149: 50-56. 10.1210/en.2007-1204.PubMed CentralView ArticlePubMedGoogle Scholar
- Greiner M, Paredes A, Rey-Ares V, Saller S, Mayerhofer A, Lara HE: Catecholamine uptake, storage, and regulated release by ovarian granulosa cells. Endocrinology. 2008, 149: 4988-4996. 10.1210/en.2007-1661.View ArticlePubMedGoogle Scholar
- Ferruz J, Barria A, Galleguillos X, Lara HE: Release of norepinephrine from the rat ovary: local modulation of gonadotropins. Biol Reprod. 1991, 45: 592-597. 10.1095/biolreprod45.4.592.View ArticlePubMedGoogle Scholar
- Wakade AR: A maximum contraction and substantial quantities of tritium can be obtained from tetraethylammonium-treated [3H]-noradrenaline preloaded, rat vas deferens in response to a single electrical shock. Br J Pharmacol. 1980, 68: 425-436.PubMed CentralView ArticlePubMedGoogle Scholar
- Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162: 156-159. 10.1016/0003-2697(87)90021-2.View ArticlePubMedGoogle Scholar
- Ojeda S, Skinner M: Puberty in the rat. The Physiology of Reproduction. Edited by: Neill JD. 2006, San Diego: Academic Press/Elsevier, 2: 2061-2126.Google Scholar
- Santoro N, Brown JR, Adel T, Skurnick JH: Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab. 1996, 81: 1495-1501. 10.1210/jc.81.4.1495.PubMedGoogle Scholar
- Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR: Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab. 1996, 81: 1038-1045. 10.1210/jc.81.3.1038.PubMedGoogle Scholar
- Lerner SP, Meredith S, Thayne WV, Butcher RL: Age-related alterations in follicular development and hormonal profiles in rats with 4-day estrous cycles. Biol Reprod. 1990, 42: 633-638. 10.1095/biolreprod42.4.633.View ArticlePubMedGoogle Scholar
- Butcher RL, Inskeep EK, Pope RS: Plasma concentrations of estradiol produced with two delivery systems in ovariectomized rats. Proc Soc Exp Biol Med. 1978, 158 (3): 475-477.View ArticlePubMedGoogle Scholar
- LaPolt PS, Matt DW, Lu JK: Progesterone implants delay age-related declines in regular estrous cyclicity and the ovarian follicular reserve in Long-Evans rats. Biol Reprod. 1998, 59: 197-201. 10.1095/biolreprod59.1.197.View ArticlePubMedGoogle Scholar
- Sopelak VM, Butcher RL: Contribution of the ovary versus hypothalamus-pituitary to termination of estrous cycles in aging rats using ovarian transplants. Biol Reprod. 1982, 27: 29-37. 10.1095/biolreprod27.1.29.View ArticlePubMedGoogle Scholar
- Mandl AM: The oestrous cycle of the adult rat after X-ray sterilization. J Endocrinol. 1959, 18: 426-433. 10.1677/joe.0.0180426.View ArticlePubMedGoogle Scholar
- Markstrom E, Svensson E, Shao R, Svanberg B, Billig H: Survival factors regulating ovarian apoptosis – dependence on follicle differentiation. Reproduction. 2002, 123: 23-30. 10.1530/rep.0.1230023.View ArticlePubMedGoogle Scholar
- Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH: Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA. 1995, 92: 1322-1326. 10.1073/pnas.92.5.1322.PubMed CentralView ArticlePubMedGoogle Scholar
- Zuo Z, Mahesh VB, Zamorano PL, Brann DW: Decreased gonadotropin-releasing hormone neurosecretory response to glutamate agonists in middle-aged female rats on proestrus afternoon: a possible role in reproductive aging?. Endocrinology. 1996, 137: 2334-2338. 10.1210/en.137.6.2334.View ArticlePubMedGoogle Scholar
- Risma KA, Hirshfield AN, Nilson JH: Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. Endocrinology. 1997, 138: 3540-3547. 10.1210/en.138.8.3540.PubMedGoogle Scholar
- Brawer JR, Munoz M, Farookhi R: Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. Biol Reprod. 1986, 35: 647-655. 10.1095/biolreprod35.3.647.View ArticlePubMedGoogle Scholar
- Dissen GA, Lara HE, Leyton V, Paredes A, Hill DF, Costa ME, Martinez-Serrano A, Ojeda SR: Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology. 2000, 141: 1073-1082. 10.1210/en.141.3.1073.PubMedGoogle Scholar
- Heider U, Pedal I, Spanel-Borowski K: Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. Fertil Steril. 2001, 75: 1141-1147. 10.1016/S0015-0282(01)01805-2.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.